Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
30
BMEZ Quote, Financials, Valuation and Earnings
Last price:
$14.94
Seasonality move
:
-7.12%
Day range:
$14.62 - $15.18
52-week range:
$14.38 - $16.59
Dividend yield:
1.19%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
512.3K
Avg. volume:
411.8K
1-year change:
1.22%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
THQ
Tekla Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BMEZ
BlackRock Health Sciences Trust II
|
$14.89 | -- | -- | -- | $0.18 | 1.19% | -- |
|
BME
Blackrock Health Sciences Trust
|
$38.15 | -- | -- | -- | $0.26 | 0.34% | -- |
|
BMED
iShares Health Innovation Active ETF
|
$25.13 | -- | -- | -- | $0.01 | 0% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$167.22 | -- | -- | -- | $1.17 | 0.7% | -- |
|
THQ
Tekla Healthcare Opportunities Fund
|
$19.26 | -- | -- | -- | $0.36 | 10.51% | -- |
|
THW
Tekla World Healthcare Fund
|
$11.29 | -- | -- | -- | $0.12 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | 1.543 | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | 0.916 | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | 1.308 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 1.249 | -- | -- |
|
THQ
Tekla Healthcare Opportunities Fund
|
-- | 0.976 | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | 0.694 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
THQ
Tekla Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- | -- |
BlackRock Health Sciences Trust II vs. Competitors
-
Which has Higher Returns BMEZ or BME?
Blackrock Health Sciences Trust has a net margin of -- compared to BlackRock Health Sciences Trust II's net margin of --. BlackRock Health Sciences Trust II's return on equity of -- beat Blackrock Health Sciences Trust's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEZBlackRock Health Sciences Trust II-- -- -- BMEBlackrock Health Sciences Trust-- -- -- -
What do Analysts Say About BMEZ or BME?
BlackRock Health Sciences Trust II has a consensus price target of --, signalling downside risk potential of --. On the other hand Blackrock Health Sciences Trust has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Health Sciences Trust II has higher upside potential than Blackrock Health Sciences Trust, analysts believe BlackRock Health Sciences Trust II is more attractive than Blackrock Health Sciences Trust.
Company Buy Ratings Hold Ratings Sell Ratings BMEZBlackRock Health Sciences Trust II0 0 0 BMEBlackrock Health Sciences Trust0 0 0 -
Is BMEZ or BME More Risky?
BlackRock Health Sciences Trust II has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Blackrock Health Sciences Trust has a beta of 0.680, suggesting its less volatile than the S&P 500 by 32.048%.
-
Which is a Better Dividend Stock BMEZ or BME?
BlackRock Health Sciences Trust II has a quarterly dividend of $0.18 per share corresponding to a yield of 1.19%. Blackrock Health Sciences Trust offers a yield of 0.34% to investors and pays a quarterly dividend of $0.26 per share. BlackRock Health Sciences Trust II pays -- of its earnings as a dividend. Blackrock Health Sciences Trust pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMEZ or BME?
BlackRock Health Sciences Trust II quarterly revenues are --, which are smaller than Blackrock Health Sciences Trust quarterly revenues of --. BlackRock Health Sciences Trust II's net income of -- is lower than Blackrock Health Sciences Trust's net income of --. Notably, BlackRock Health Sciences Trust II's price-to-earnings ratio is -- while Blackrock Health Sciences Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Health Sciences Trust II is -- versus -- for Blackrock Health Sciences Trust. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEZBlackRock Health Sciences Trust II-- -- -- -- BMEBlackrock Health Sciences Trust-- -- -- --
-
Which has Higher Returns BMEZ or BMED?
iShares Health Innovation Active ETF has a net margin of -- compared to BlackRock Health Sciences Trust II's net margin of --. BlackRock Health Sciences Trust II's return on equity of -- beat iShares Health Innovation Active ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEZBlackRock Health Sciences Trust II-- -- -- BMEDiShares Health Innovation Active ETF-- -- -- -
What do Analysts Say About BMEZ or BMED?
BlackRock Health Sciences Trust II has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Health Innovation Active ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Health Sciences Trust II has higher upside potential than iShares Health Innovation Active ETF, analysts believe BlackRock Health Sciences Trust II is more attractive than iShares Health Innovation Active ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEZBlackRock Health Sciences Trust II0 0 0 BMEDiShares Health Innovation Active ETF0 0 0 -
Is BMEZ or BMED More Risky?
BlackRock Health Sciences Trust II has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Health Innovation Active ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BMEZ or BMED?
BlackRock Health Sciences Trust II has a quarterly dividend of $0.18 per share corresponding to a yield of 1.19%. iShares Health Innovation Active ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. BlackRock Health Sciences Trust II pays -- of its earnings as a dividend. iShares Health Innovation Active ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMEZ or BMED?
BlackRock Health Sciences Trust II quarterly revenues are --, which are smaller than iShares Health Innovation Active ETF quarterly revenues of --. BlackRock Health Sciences Trust II's net income of -- is lower than iShares Health Innovation Active ETF's net income of --. Notably, BlackRock Health Sciences Trust II's price-to-earnings ratio is -- while iShares Health Innovation Active ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Health Sciences Trust II is -- versus -- for iShares Health Innovation Active ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEZBlackRock Health Sciences Trust II-- -- -- -- BMEDiShares Health Innovation Active ETF-- -- -- --
-
Which has Higher Returns BMEZ or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to BlackRock Health Sciences Trust II's net margin of --. BlackRock Health Sciences Trust II's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEZBlackRock Health Sciences Trust II-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About BMEZ or FBT?
BlackRock Health Sciences Trust II has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Health Sciences Trust II has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe BlackRock Health Sciences Trust II is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings BMEZBlackRock Health Sciences Trust II0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is BMEZ or FBT More Risky?
BlackRock Health Sciences Trust II has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.671, suggesting its less volatile than the S&P 500 by 32.903%.
-
Which is a Better Dividend Stock BMEZ or FBT?
BlackRock Health Sciences Trust II has a quarterly dividend of $0.18 per share corresponding to a yield of 1.19%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.7% to investors and pays a quarterly dividend of $1.17 per share. BlackRock Health Sciences Trust II pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMEZ or FBT?
BlackRock Health Sciences Trust II quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. BlackRock Health Sciences Trust II's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, BlackRock Health Sciences Trust II's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Health Sciences Trust II is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEZBlackRock Health Sciences Trust II-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns BMEZ or THQ?
Tekla Healthcare Opportunities Fund has a net margin of -- compared to BlackRock Health Sciences Trust II's net margin of --. BlackRock Health Sciences Trust II's return on equity of -- beat Tekla Healthcare Opportunities Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEZBlackRock Health Sciences Trust II-- -- -- THQTekla Healthcare Opportunities Fund-- -- -- -
What do Analysts Say About BMEZ or THQ?
BlackRock Health Sciences Trust II has a consensus price target of --, signalling downside risk potential of --. On the other hand Tekla Healthcare Opportunities Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Health Sciences Trust II has higher upside potential than Tekla Healthcare Opportunities Fund, analysts believe BlackRock Health Sciences Trust II is more attractive than Tekla Healthcare Opportunities Fund.
Company Buy Ratings Hold Ratings Sell Ratings BMEZBlackRock Health Sciences Trust II0 0 0 THQTekla Healthcare Opportunities Fund0 0 0 -
Is BMEZ or THQ More Risky?
BlackRock Health Sciences Trust II has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tekla Healthcare Opportunities Fund has a beta of 0.935, suggesting its less volatile than the S&P 500 by 6.506%.
-
Which is a Better Dividend Stock BMEZ or THQ?
BlackRock Health Sciences Trust II has a quarterly dividend of $0.18 per share corresponding to a yield of 1.19%. Tekla Healthcare Opportunities Fund offers a yield of 10.51% to investors and pays a quarterly dividend of $0.36 per share. BlackRock Health Sciences Trust II pays -- of its earnings as a dividend. Tekla Healthcare Opportunities Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMEZ or THQ?
BlackRock Health Sciences Trust II quarterly revenues are --, which are smaller than Tekla Healthcare Opportunities Fund quarterly revenues of --. BlackRock Health Sciences Trust II's net income of -- is lower than Tekla Healthcare Opportunities Fund's net income of --. Notably, BlackRock Health Sciences Trust II's price-to-earnings ratio is -- while Tekla Healthcare Opportunities Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Health Sciences Trust II is -- versus -- for Tekla Healthcare Opportunities Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEZBlackRock Health Sciences Trust II-- -- -- -- THQTekla Healthcare Opportunities Fund-- -- -- --
-
Which has Higher Returns BMEZ or THW?
Tekla World Healthcare Fund has a net margin of -- compared to BlackRock Health Sciences Trust II's net margin of --. BlackRock Health Sciences Trust II's return on equity of -- beat Tekla World Healthcare Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEZBlackRock Health Sciences Trust II-- -- -- THWTekla World Healthcare Fund-- -- -- -
What do Analysts Say About BMEZ or THW?
BlackRock Health Sciences Trust II has a consensus price target of --, signalling downside risk potential of --. On the other hand Tekla World Healthcare Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Health Sciences Trust II has higher upside potential than Tekla World Healthcare Fund, analysts believe BlackRock Health Sciences Trust II is more attractive than Tekla World Healthcare Fund.
Company Buy Ratings Hold Ratings Sell Ratings BMEZBlackRock Health Sciences Trust II0 0 0 THWTekla World Healthcare Fund0 0 0 -
Is BMEZ or THW More Risky?
BlackRock Health Sciences Trust II has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tekla World Healthcare Fund has a beta of 0.927, suggesting its less volatile than the S&P 500 by 7.302%.
-
Which is a Better Dividend Stock BMEZ or THW?
BlackRock Health Sciences Trust II has a quarterly dividend of $0.18 per share corresponding to a yield of 1.19%. Tekla World Healthcare Fund offers a yield of 0% to investors and pays a quarterly dividend of $0.12 per share. BlackRock Health Sciences Trust II pays -- of its earnings as a dividend. Tekla World Healthcare Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMEZ or THW?
BlackRock Health Sciences Trust II quarterly revenues are --, which are smaller than Tekla World Healthcare Fund quarterly revenues of --. BlackRock Health Sciences Trust II's net income of -- is lower than Tekla World Healthcare Fund's net income of --. Notably, BlackRock Health Sciences Trust II's price-to-earnings ratio is -- while Tekla World Healthcare Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Health Sciences Trust II is -- versus -- for Tekla World Healthcare Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEZBlackRock Health Sciences Trust II-- -- -- -- THWTekla World Healthcare Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
